Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Bristol-Myers Squibb expands manufacturing agreement with Lonza Bristol-Myers Squibb (BMS) has expanded its existing multi-year biologics manufacturing agreement with Swiss chemicals and biotechnology firm Lonza. Production & Manufacturing > Manufacturing > News
Medivation, Astellas to initiate Phase III trial of prostate cancer drug enzalutamide By PBR Staff Writer
Medivation and Astellas are planning to begin a Phase III clinical trial of enzalutamide in men with high-risk, hormone-sensitive, non-metastatic prostate cancer.
News Affinivax launches new conjugate vaccine for Ggobal impact on infectious diseases Affinivax, a biotechnology company dedicated to developing novel vaccines, has announced its launch with a $4m investment from the Bill & Melinda Gates Foundation.
News ASLAN selects Medidata as enterprise-wide technology platform to improve clinical development Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company.
News
Tribute Pharmaceuticals secures uracyst patent in Europe Tribute Pharmaceuticals Canada has received a patent approval from the European Patent Office (EPO) for intellectual property central to one of the Company's lead products, Uracyst/Uropol (a sterile sodium chondroitin sulfate solution, 2%), for the treatment of interstitial cystitis by instillation into the bladder of a patient.
News Levolta receives US patent for new investigational therapy for controlling osteoarthritis Levolta Pharmaceuticals an emerging leader in developmental osteoarthritis (OA) therapy, has announced that the US Patent and Trademark Office has awarded the company a patent for its novel VOLT01, a derivative of zoledronic acid (ZA), a proposed commercial product that has shown promise as a disease-modifying drug in clinical trials.
News Cirrus Pharmaceuticals to invest in cGMP manufacturing suite in US Cirrus Pharmaceuticals, a Kemwell company, which is a 100% services oriented company providing pharmaceutical contract development and manufacturing services, has announced that it will be investing in a flexible cGMP suite in its facility in RTP, North Carolina.
News

Latest News and Insight by Sector

Production & Manufacturing

Affinivax launches new conjugate vaccine for Ggobal impact on infectious diseases
Affinivax, a biotechnology company dedicated to developing novel vaccines, has announced its launch with a $4m investment from the Bill & Melinda Gates Foundation.
News
Tribute Pharmaceuticals secures uracyst patent in Europe
Tribute Pharmaceuticals Canada has received a patent approval from the European Patent Office (EPO) for intellectual property central to one of the Company's lead products, Uracyst/Uropol (a sterile sodium chondroitin sulfate solution, 2%), for the treatment of interstitial cystitis by instillation into the bladder of a patient.
News

Drug Research

MEI Pharma begins dosing in ME-344 Phase Ib trial for small cell lung and ovarian cancers
By PBR Staff Writer
US-based MEI Pharma has dosed the first patient in a cohort-expansion stage of its Phase Ib clinical trial of ME-344 in combination with topotecan to treat patients with small cell lung or ovarian cancer who failed initial therapy.
News
Relmada adds $15m in capital to accelerate development of pain treatment drugs
Relmada Therapeutics, a biopharmaceutical firm with four novel pain treatment drugs currently under development in its pipeline, has received a healthy injection of more than $15m in capital last week that will assist the company in the advancement of its work to bring those products to the largest drug prescription market in the world - the treatment of pain.
News

Inward Investment

Endo International to buy Auxilium Pharmaceuticals for $2.6bn
By PBR Staff Writer
Ireland-based Endo International has signed an agreement to acquire Auxilium Pharmaceuticals, in a deal that is worth nearly $2.6bn.
News
Endo offers $2.2bn to acquire Auxilium
By PBR Staff Writer
Irish pain drugmaker Endo International has proposed $2.2bn offer to acquire biopharmaceutical company Auxilium Pharmaceuticals.
News

Packaging

Packaging Coordinators completes acquisition of Biotec
By PBR Staff Writer
Packaging services provider Packaging Coordinators (PCI) has completed the acquisition of UK-based pharmaceutical services provider Biotec for an undisclosed amount.
News
Biologics adds frozen storage capabilities to clinical research services
By PBR Staff Writer
Biologics’ Clinical Research Services has announced the addition of frozen storage capabilities to its state-of-the-art facilities and cold-chain packaging and distribution.
News

Contract Research & Services

Medivation, Astellas to initiate Phase III trial of prostate cancer drug enzalutamide
By PBR Staff Writer
Medivation and Astellas are planning to begin a Phase III clinical trial of enzalutamide in men with high-risk, hormone-sensitive, non-metastatic prostate cancer.
News
Auspex begins Phase III AIM-TD trial of SD-809 in patients with tardive dyskinesia
By PBR Staff Writer
Auspex Pharmaceuticals has started patient enrollment in a multi-center Phase III clinical trial of its investigational drug SD-809 (deutetrabenazine) to treat people with tardive dyskinesia, a debilitating and often irreversible movement disorder.
News

Automation

ASLAN selects Medidata as enterprise-wide technology platform to improve clinical development
Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company.
News
Onxeo reports positive preliminary results from Validive Phase II trial for oral mucositis
By PBR Staff Writer
French biopharmaceutical firm Onxeo has reported positive preliminary top-line results from its Phase II clinical trial of Validive (mucoadhesive buccal tablet MBT clonidine Lauriad) to prevent severe oral mucositis (OM).
News

Regulatory Affairs

RetroSense gets FDA orphan drug status for RST-001 to treat retinitis pigmentosa
By PBR Staff Writer
US-based RetroSense Therapeutics has received orphan drug designation from the Food and Drug Administration (FDA) for its lead product RST-001 to treat retinitis pigmentosa (RP), a genetic condition which leads to the progressive degeneration of rod and cone photoreceptors.
News
FDA grants accelerated approval for Pfizer' meningococcal B vaccine Trumenba
By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted accelerated approval for Pfizer's Trumenba (meningococcal group B vaccine) for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals aged 10-25 years.
News

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Reports Buy online from $250



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery